Floatz logo

3 assets in Primary Melanoma Of The Central Nervous System

Therapeutic assets addressing Primary Melanoma Of The Central Nervous System, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Atezolizumab
Primary Melanoma Of The Central Nervous System
M.D. Anderson Cancer CenterP2CCC (53)
Cobimetinib
Primary Melanoma Of The Central Nervous System
M.D. Anderson Cancer CenterP2CCC (53)
Nivolumab
Primary Melanoma Of The Central Nervous System
M.D. Anderson Cancer CenterP1CC (43)